MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it received approval from Health Canada s Pest Management Regulatory Agency (PMRA) to.
MustGrow Biologics Corp. is pleased to announce the approval of Health Canada s Pest Management Regulatory Agency to commence large-scale field trials via NexusBioAg s 2024 BioAdvantage Trials.
MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FSE: 0C0) (
MustGrow ) is pleased to announce successful greenhouse efficacy results of its patented mustard-derived biopesticide on
Aphanomyces euteiches zoospores (
Aphanomyces ) via an independent third party. Control in greenhouse soil was recorded across a range of economic application rates. MustGrow will advance to larger scale field tests in 2021 to be conducted under the recently-announced collaborative Canadian field trials program with NexusBioAg, a division of Univar Solutions Inc. Study results and applicability are patent-protected under MustGrow s existing suite of issued patents.
MustGrow s crop protection technology has consistently demonstrated efficacious benefits similar to chemistry-based synthetic chemical products without the harmful safety profile often associated with some synthetic chemical products. The development of safe and effective biopesticides will be critical for future food securi